Potential Therapy, CT1812, Seen as Safe and Able to Target Disease Markers, Cognition Reports Alzheimer’s News Today By John Harbison|2017-11-14T12:02:42-08:00November 14, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Potential Therapy, CT1812, Seen as Safe and Able to Target Disease Markers, Cognition Reports Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
